Literature DB >> 20713860

Pitfalls of using composite primary end points in the presence of competing risks.

Loren K Mell, Jong-Hyeon Jeong.   

Abstract

Mesh：

Year:  2010        PMID： 20713860     DOI： 10.1200/JCO.2010.30.2802

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

1.  Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer.

Authors:  Loren K Mell; Hanjie Shen; Phuc Felix Nguyen-Tân; David I Rosenthal; Kaveh Zakeri; Lucas K Vitzthum; Steven J Frank; Peter B Schiff; Andy M Trotti; James A Bonner; Christopher U Jones; Sue S Yom; Wade L Thorstad; Stuart J Wong; George Shenouda; John A Ridge; Qiang E Zhang; Quynh-Thu Le
Journal:  Clin Cancer Res       Date:  2019-08-16       Impact factor: 12.531

2.  Moving beyond disease-focused decision making: understanding competing risks to personalize lung cancer treatment for older adults.

Authors:  Lauren J Taylor; James D Maloney
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

3.  Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer.

Authors:  Cameron W Swanick; Patricia J Eifel; Jinhai Huo; Larissa A Meyer; Grace L Smith
Journal:  Gynecol Oncol       Date:  2017-05-12       Impact factor: 5.482

4.  Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer.

Authors:  Alex K Bryant; Elena J Sojourner; Lucas K Vitzthum; Kaveh Zakeri; Hanjie Shen; Cammie Nguyen; James D Murphy; Joseph A Califano; Ezra E W Cohen; Loren K Mell
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

5.  Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794.

Authors:  Kaveh Zakeri; Brent S Rose; Sachin Gulaya; Anthony V D'Amico; Loren K Mell
Journal:  Contemp Clin Trials       Date:  2012-10-11       Impact factor: 2.226

Review 6.  Management of older or unfit patients with acute myeloid leukemia.

Authors:  R B Walter; E H Estey
Journal:  Leukemia       Date:  2014-07-09       Impact factor: 11.528

7.  Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events.

Authors:  Ruben Carmona; Kaveh Zakeri; Garrett Green; Lindsay Hwang; Sachin Gulaya; Beibei Xu; Rohan Verma; Casey W Williamson; Daniel P Triplett; Brent S Rose; Hanjie Shen; Florin Vaida; James D Murphy; Loren K Mell
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

8.  Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research.

Authors:  Ina Jazić; Deborah Schrag; Daniel J Sargent; Sebastien Haneuse
Journal:  J Natl Cancer Inst       Date:  2016-07-05       Impact factor: 13.506

9.  Validated competing event model for the stage I-II endometrial cancer population.

Authors:  Ruben Carmona; Sachin Gulaya; James D Murphy; Brent S Rose; John Wu; Sonal Noticewala; Michael T McHale; Catheryn M Yashar; Florin Vaida; Loren K Mell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-15       Impact factor: 7.038

10.  Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer.

Authors:  Siddhartha Devarakonda; Federico Rotolo; Ming-Sound Tsao; Irena Lanc; Elisabeth Brambilla; Ashiq Masood; Ken A Olaussen; Robert Fulton; Shingo Sakashita; Anne McLeer-Florin; Keyue Ding; Gwénaël Le Teuff; Frances A Shepherd; Jean-Pierre Pignon; Stephen L Graziano; Robert Kratzke; Jean-Charles Soria; Lesley Seymour; Ramaswamy Govindan; Stefan Michiels
Journal:  J Clin Oncol       Date:  2018-08-14       Impact factor: 50.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.